Image Not Found On Media Library
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Pre-Order CRaFT 2025
    • 2024 CRaFT Report
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-r
Image Not Found On Media Library
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Pre-Order CRaFT 2025
    • 2024 CRaFT Report
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

NEW Canadian Reimbursement Trends and Timelines Report – now available!

September 18, 2019
-
Market Access News, Publications, What's New
-
Posted by MORSE - < 1 min read.

Toronto, September 18, 2019 – MORSE Consulting is pleased to launch the Canadian Reimbursement Trends and Timelines report – a  comprehensive, credible and relevant source of market access intelligence.

The market access pathway in Canada is going through an unprecedented level of change and uncertainty.  This 58-page PowerPoint report is aimed at not only helping market access professionals plan for future launches but can be a valuable education tool for both internal and external stakeholders.

Please click here to learn more about our new report.

 

About the Authors:

MORSE Consulting Inc. is a leader in strategic pharmaceutical market access consulting in Canada. Our team has significant expertise in reimbursement strategy in a wide range of therapeutic areas and has built a reputation for providing meaningful strategic insights. MORSE has established strong, constructive relationships with healthcare stakeholders and a proven track record for delivering impactful results to its clients.

 

Share
Tags
CADTH
CDR
HTA
INESSS
Market Access Strategy
pCODR
pCPA
pCPAO
Public Payers
Reimbursement strategy
TTL
← PREVIOUS POST
Average Time Under pCPA Consideration Below 30 Days for the 3rd Consecutive Month
NEXT POST →
15 Oncology Files either Completed, Initiated or new Under Consideration

Contact Us

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

Pre-Order 2025 Report

2025 Canadian Reimbursement and Forecasting Timelines Report

Social
Connect & Follow:
Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
NEW Canadian Reimbursement Trends and Timelines Report – now available!
Learn More
Learn More